Mark E. Morrison
8 works · 977 citations · h-index 6
Top works
- Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer
- A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase.
- In vitro studies of 2,4-dihydroxyphenylalanine, a prodrug targeted against malignant melanoma cells.
- Novel substrates for tyrosinase serve as precursors of 6-hydroxydopamine and 6-hydroxydopa
- Randomized Phase II Trial of Docetaxel/Irinotecan and Gemcitabine/Irinotecan With or Without Celecoxib in the Second-Line Treatment of Non–Small-Cell Lung Cancer
- Assignment of the DPP4 Gene Encoding Adenosine Deaminase Binding Protein (CD26/Dipeptidylpeptidase IV) to 2q23
- 2,4‐DOPA: A Targeted Prodrug of Potential Use in the Treatment of Malignant Melanomaa
- In vitro studies of 2,4-dihydroxyphE against malignant melanoma cells (tyrosinase/chemotherapy)